(Hong Kong, 15 January 2009) – Lee’s Pharmaceutical Holdings Limited (GEM Stock: 8221; Website: www.leespharm.com) (“Leespharm”) announced today that the Group has successfully obtained the renewal of Imported Drug License (“IDL”) for importing of Co-dergocrine Mesylate into the People’s Republic of China.